TY-DOX400-™ provides a synergistic combination of Tylosin, a macrolide
effective against Mycoplasma and Gram-positive bacteria, and
Doxycycline, a broad-spectrum tetracycline active against both
Gram-positive and Gram negative organisms. Together, they offer
comprehensive control of chronic respiratory disease (CRD), infectious
sinusitis, and mixed bacterial infections that impair growth and feed efficiency.
The formulation dissolves rapidly and completely in water, ensuring uniform
dosing through drinker systems.